Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Alzamend Neuro, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 33 | 26 | −7 |
| Shares | 6.99M | 6.22M | −764.2K (−10.9%) |
| Value | $3.98M | $2.64M | −$1.34M (−33.6%) |
New holders (1)
Institutions that held Alzamend Neuro, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advisor Group Holdings, Inc. | 1,000 | $425 | 0.00% |
Sold out (8)
Institutions that held Alzamend Neuro, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HRT Financial LP | 57,080 | $32.0K |
| Renaissance Technologies LLC | 49,800 | $28.0K |
| Ergoteles LLC | 23,574 | $13.3K |
| Two Sigma Investments, LP | 19,313 | $10.9K |
| Freedom Wealth Alliance, LLC | 15,000 | $8.47K |
| Ground Swell Capital, LLC | 13,619 | $7.69K |
| StoneX Group Inc. | 11,005 | $6.22K |
| Money Concepts Capital Corp | 250 | $141 |